|Bid||421.12 x 1000|
|Ask||421.42 x 800|
|Day's Range||413.92 - 423.59|
|52 Week Range||219.79 - 460.21|
|Beta (5Y Monthly)||1.15|
|PE Ratio (TTM)||54.42|
|Earnings Date||Nov. 03, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||449.18|
CAMBRIDGE, Mass., October 20, 2021--Charles River expands CRADL facilities in Cambridge, including growth of Binney Street site and the addition of a location on Bent Street.
Charles River's (CRL) recent partnership will enable the company to improve drug discovery projects by allowing structure-based design for a greater portfolio of targets.
WILMINGTON, Mass., October 18, 2021--Charles River Laboratories International, Inc. (NYSE: CRL) and ATEM Structural Discovery (ATEM) today announced the formation of a strategic partnership to provide clients access to ATEM’s cryo-electron microscopy (cryo-EM) service solutions. Cryo-EM is a technique that determines the 3D structures of proteins and is utilized to identify how proteins function, how they malfunction in disease and the most effective way to target them with therapies.